E-Scopics S.A.S.

E-Scopics is a software-centric ultrasound imaging company pioneering a fully digital, cloud-connected diagnostic platform. Founded by ultrasound and signal processing veterans with 20+ years of industry experience, the company transforms standard consumer devices (PCs, tablets, smartphones) into high-end point-of-care ultrasound diagnostic tools via downloadable software and proprietary smart digital transducers. The core innovation replaces traditional hardware-centric ultrasound with a software-only architecture that leverages ultrafast imaging, raw per-channel RF data capture, and quantitative imaging biomarkers for non-expert users. E-Scopics' first commercial product is Hepatoscope®, an FDA-cleared and CE-marked system designed for point-of-care liver disease assessment (MASLD/MASH risk stratification) that provides liver stiffness and quantitative ultrasound parameters in 4 minutes. The company operates a B2B OEM and research licensing platform, offering foundational ultrasound technology to healthcare and corporate partners. E-Scopics is supported by France 2030 through the €6.7M POCUSI project and has received recognition from Prix Galien MedTech, i-Lab Award, InvestHorizon, and other innovation programs. Primary markets include hepatology, gastroenterology, endocrinology, and primary care. The platform emphasizes accessibility, reproducibility, and clinical quantification for chronic disease surveillance.